mCloud Enters Into Technology Continuation Agreement With Agnity Global; Terms Not Disclosed

mCloud Technologies Corp. (NASDAQ:MCLD) (TSXV:MCLD), ("mCloud" or the "Company") a leading provider of AI-powered asset management and Environmental, Social, and Governance ("ESG")

mCloud Technologies Corp. (NASDAQ:MCLD) (TSXV:MCLD), (“mCloud” or the “Company”) a leading provider of AI-powered asset management and Environmental, Social, and Governance (“ESG”) solutions today announced that it has entered into a technology continuation agreement with Agnity Global Inc. (the “Technology Continuation Agreement” and “Agnity” respectively), enabling mCloud to build on the success of its existing relationship with Agnity.

Total
0
Shares
Related Posts
Read More

Centessa Pharmaceuticals To Present Additional Data From Open-Label Extension Of Phase 2a Study Of SerpinPC For Hemophilia At The 16th Annual Congress Of The European Association For Haemophilia And Allied Disorders On February 10, 2023

 Centessa Pharmaceuticals plc (NASDAQ:CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced that the Company will present

CNTA